Alterity Therapeutics (NASDAQ:ATHE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Alterity Therapeutics (ATHE) operate in?

Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	10.00 / 12.18K
Day Range	- - -
52 Wk Range	1.01 - 5.41
Market Cap	$9.44M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	0.04%
Days to Cover	1

Recent News

Alterity Up on Interim Data From Advance MSA Study

Shares of Alterity Therapeutics (NASDAQ: ATHE) were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for treating patients with multiple system atrophy, a rare neurodegenerative disease.

Zacks

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Avi Kapoor

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	10.00 / 12.18K
Day Range	- - -
52 Wk Range	1.01 - 5.41
Market Cap	$9.44M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	0.04%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alterity Therapeutics (ATHE) stock?

You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.

View our list of the best stock brokerages

Who are Alterity Therapeutics (ATHE) competitors?

Other companies in Alterity Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Imunon (NASDAQ:IMNN) and T2 Biosystems (NASDAQ:TTOO).

What is the forecast, or price target, for Alterity Therapeutics (ATHE) stock?

Alterity Therapeutics has a consensus price target of $5.67.

What is the current price for Alterity Therapeutics (ATHE)?

The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $1.08 last updated November 18, 2024 at 7:22 PM EST.

Does Alterity Therapeutics (ATHE) pay a dividend?

There are no upcoming dividends for Alterity Therapeutics.

When is Alterity Therapeutics (NASDAQ:ATHE) reporting earnings?

Alterity Therapeutics’s Q3 earnings are confirmed for Saturday, February 15, 2025.

Is Alterity Therapeutics (ATHE) going to split?

There is no upcoming split for Alterity Therapeutics.

What sector and industry does Alterity Therapeutics (ATHE) operate in?

Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Alterity Therapeutics

Alterity Therapeutics (ATHE) Forecast